Study S000025

Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control Addendum to: A Randomized, Double-Blind, Parallel-Group, Multicenter Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Long-Acting Release to Those of Sitagliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus Treated With Metformin (Study BCB106)

ClinicalTrials.gov record

Registration

Registration: NCT00806520
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 16
Start: 2008-04
Primary completion: 2011-08
Lead sponsor: HealthPartners Institute
Conditions: Type 2 Diabetes
Results posted: FALSE

Registered primary outcomes

None registered.

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.